PLAINSBORO, N.J., May 3, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) is featuring the CUSA NXT(TM) ultrasonic tissue ablation system at the 2009 American Association of Neurological Surgeons Annual Meeting in San Diego, California, May 2-6, 2009. The CUSA NXT(TM) ultrasonic tissue ablation system provides powerful and precise soft tissue removal with built-in irrigation and aspiration, and marks a significant new addition to Integra’s market-leading CUSA(R) portfolio. Integra’s CUSA NXT(TM) system is the result of Integra’s extensive ultrasonic tissue ablation engineering expertise and development efforts. The CUSA NXT(TM) system has received FDA clearance in the United States and CE Mark Certification in the European Union.
